JP2022520817A5 - - Google Patents
Info
- Publication number
- JP2022520817A5 JP2022520817A5 JP2021547401A JP2021547401A JP2022520817A5 JP 2022520817 A5 JP2022520817 A5 JP 2022520817A5 JP 2021547401 A JP2021547401 A JP 2021547401A JP 2021547401 A JP2021547401 A JP 2021547401A JP 2022520817 A5 JP2022520817 A5 JP 2022520817A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- antibody
- composition according
- pharmaceutical composition
- containing seq
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201962806237P | 2019-02-15 | 2019-02-15 | |
| US62/806,237 | 2019-02-15 | ||
| PCT/CA2020/050195 WO2020163962A1 (en) | 2019-02-15 | 2020-02-14 | Fcmr-binding molecules and uses thereof |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2022520817A JP2022520817A (ja) | 2022-04-01 |
| JP2022520817A5 true JP2022520817A5 (https=) | 2023-02-21 |
Family
ID=72043773
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2021547401A Pending JP2022520817A (ja) | 2019-02-15 | 2020-02-14 | Ｆｃｍｒ結合分子およびそれらの使用 |
Country Status (14)
| Country | Link |
|---|---|
| US (1) | US12286476B2 (https=) |
| EP (1) | EP3924388A4 (https=) |
| JP (1) | JP2022520817A (https=) |
| KR (1) | KR20210139273A (https=) |
| CN (1) | CN113993895A (https=) |
| AU (1) | AU2020222408A1 (https=) |
| BR (1) | BR112021016102A2 (https=) |
| CA (1) | CA3130225A1 (https=) |
| EA (1) | EA202192254A1 (https=) |
| IL (1) | IL285585A (https=) |
| MX (1) | MX2021009767A (https=) |
| SG (1) | SG11202108837WA (https=) |
| TW (1) | TWI857009B (https=) |
| WO (1) | WO2020163962A1 (https=) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| MX2021009767A (es) | 2019-02-15 | 2021-11-17 | Univ Health Network | Moleculas de union de fmcr y usos de las mismas. |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5530101A (en) | 1988-12-28 | 1996-06-25 | Protein Design Labs, Inc. | Humanized immunoglobulins |
| US5859205A (en) | 1989-12-21 | 1999-01-12 | Celltech Limited | Humanised antibodies |
| EP1400536A1 (en) | 1991-06-14 | 2004-03-24 | Genentech Inc. | Method for making humanized antibodies |
| WO1994004679A1 (en) | 1991-06-14 | 1994-03-03 | Genentech, Inc. | Method for making humanized antibodies |
| AU2004297616B2 (en) | 2003-12-04 | 2008-12-18 | Xencor, Inc. | Methods of generating variant proteins with increased host string content and compositions thereof |
| CA2867444C (en) * | 2012-03-16 | 2021-04-13 | University Health Network | Compositions containing soluble toso protein and uses thereof |
| EP2970451A1 (en) * | 2013-03-14 | 2016-01-20 | Amgen Inc. | Chrdl-1 antigen binding proteins and methods of treatment |
| US9493561B2 (en) * | 2013-07-03 | 2016-11-15 | University Health Network | Antibodies to Toso |
| AU2015225867B2 (en) * | 2014-03-07 | 2020-02-06 | University Health Network | Methods and compositions for modifying the immune response |
| CA2961439A1 (en) | 2014-11-05 | 2016-05-12 | Genentech, Inc. | Anti-fgfr2/3 antibodies and methods using same |
| US20180201676A1 (en) | 2015-02-11 | 2018-07-19 | University Health Network | Methods and compositions for modulating lilr proteins |
| ES2690420T3 (es) * | 2015-05-28 | 2018-11-20 | Universität Zu Köln | Receptor de antígeno quimérico anti-toso y su uso |
| WO2018119425A2 (en) | 2016-12-22 | 2018-06-28 | Icahn School Of Medicine At Mount Sinai | Anti-lilrb3 antibodies and methods of use thereof |
| MX2021009767A (es) | 2019-02-15 | 2021-11-17 | Univ Health Network | Moleculas de union de fmcr y usos de las mismas. |
-
2020
- 2020-02-14 MX MX2021009767A patent/MX2021009767A/es unknown
- 2020-02-14 BR BR112021016102A patent/BR112021016102A2/pt unknown
- 2020-02-14 EP EP20756467.5A patent/EP3924388A4/en active Pending
- 2020-02-14 SG SG11202108837WA patent/SG11202108837WA/en unknown
- 2020-02-14 US US17/430,311 patent/US12286476B2/en active Active
- 2020-02-14 WO PCT/CA2020/050195 patent/WO2020163962A1/en not_active Ceased
- 2020-02-14 CA CA3130225A patent/CA3130225A1/en active Pending
- 2020-02-14 CN CN202080025378.0A patent/CN113993895A/zh active Pending
- 2020-02-14 TW TW109104713A patent/TWI857009B/zh active
- 2020-02-14 EA EA202192254A patent/EA202192254A1/ru unknown
- 2020-02-14 KR KR1020217029786A patent/KR20210139273A/ko not_active Ceased
- 2020-02-14 JP JP2021547401A patent/JP2022520817A/ja active Pending
- 2020-02-14 AU AU2020222408A patent/AU2020222408A1/en active Pending
-
2021
- 2021-08-12 IL IL285585A patent/IL285585A/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US12258411B2 (en) | Anti-CCR8 antibodies and uses thereof | |
| EP3411398B1 (en) | Targeted therapeutic agents and uses thereof | |
| JP6866294B2 (ja) | 抗ｐｄ−ｌ１抗体 | |
| US20210024631A1 (en) | Bi-functional proteins and construction thereof | |
| US12583898B2 (en) | Therapeutic interferon alpha 1 proteins | |
| TWI890481B (zh) | 雙特異性抗體 | |
| JP2020520665A5 (https=) | ||
| JP2019527543A5 (https=) | ||
| CA3023881A1 (en) | Therapeutic targeting of non-cellular structures | |
| US20260109748A1 (en) | Modulation of dendritic cell lineages | |
| JP2019534891A5 (https=) | ||
| JP2023515223A5 (https=) | ||
| US20240199714A1 (en) | Il-2 based constructs | |
| JP2022528005A5 (https=) | ||
| JP6811733B2 (ja) | リンパ腫又は白血病におけるリンパ球増加症を誘導することにおける使用のためのヒトｃｓｆ−１ｒに対する抗体 | |
| JP2022513689A5 (https=) | ||
| JP2021512107A5 (https=) | ||
| JP2022517809A5 (https=) | ||
| JP2022516071A5 (https=) | ||
| JP2022513421A5 (https=) | ||
| JP2023543896A5 (https=) | ||
| JP2022522815A5 (https=) | ||
| US20230002493A1 (en) | Pd-l1 targeted chimeric proteins and uses thereof | |
| SG194362A1 (en) | Composition for treating disease | |
| JP2022520817A5 (https=) |